Retatrutide 20mg
A triple-receptor agonist investigated for its combined GLP-1, GIP and glucagon receptor activity in metabolic research models.
Mix & Match Bundle Savings
2+
−10%
3+
−15%
4+
−20%
6+
−25%
8+
−30%
10+
−40%
Mix any eligible peptides — savings apply automatically in your bag.
Form
Lyophilised powder
Purity
≥99%
Quantity
20MG
Storage
Store at 2–8°C
The Science
Research Overview
Retatrutide is a synthetic triple agonist studied for simultaneous activity at the GLP-1, GIP and glucagon receptors. Published preclinical work has examined its effects on energy expenditure, lipid handling and body composition endpoints. DKD PEPS supplies each 30mg vial as a lyophilised powder, independently tested for identity and purity before release, with the corresponding batch certificate available on request. Supplied strictly for laboratory research use.
This product is supplied for laboratory research use only — not for human consumption, and not for diagnostic or therapeutic use.
- ≥99% purity verified by HPLC
- Reconstitute with 2mL BAC water
- Store at 2–8°C, protect from light
- Discreet, unmarked Australian shipping
Customer Reviews
Be the first to review
No reviews for this product yet.
Related
